PUL ID

PUL0556

PubMed

25139987, Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12901-6. doi: 10.1073/pnas.1407344111. Epub 2014 Aug 19.

Characterization method

gene deletion mutant and growth assay,qRT-PCR,microarray,enzyme activity assay

Genomic accession number

NC_016776.1

Nucelotide position range

1583511-1593729

Substrate

N-glycan

Loci

BF638R_1323-BF638R_1330

Species

Bacteroides fragilis/817

Degradation or Biosynthesis

degradation

Cluster number

1

Gene name

Gene position

Gene type

Found by CGCFinder?

- 1 - 600 (-) TF: DBD-Pfam|GerE No
- 766 - 1776 (+) STP: STP|FecR No
- 2087 - 5392 (+) TC: gnl|TC-DB|Q8A8X1|1.B.14.6.13 Yes
- 5405 - 6949 (+) TC: gnl|TC-DB|Q8A8X0|8.A.46.2.1 Yes
- 6977 - 8029 (+) CAZyme: GH18 Yes
- 8047 - 9183 (+) CDS No
- 9206 - 10219 (+) CDS No

PUL ID

PUL0556

PubMed

25139987, Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12901-6. doi: 10.1073/pnas.1407344111. Epub 2014 Aug 19.

Title

Efficient utilization of complex N-linked glycans is a selective advantage for Bacteroides fragilis in extraintestinal infections.

Author

Cao Y, Rocha ER, Smith CJ

Abstract

Bacteroides fragilis is the most common anaerobe isolated from clinical infections, and in this report we demonstrate a characteristic of the species that is critical to their success as an opportunistic pathogen. Among the Bacteroides spp. in the gut, B. fragilis has the unique ability of efficiently harvesting complex N-linked glycans from the glycoproteins common to serum and serous fluid. This activity is mediated by an outer membrane protein complex designated as Don. Using the abundant serum glycoprotein transferrin as a model, it has been shown that B. fragilis alone can rapidly and efficiently deglycosylate this protein in vitro and that transferrin glycans can provide the sole source of carbon and energy for growth in defined media. We then showed that transferrin deglycosylation occurs in vivo when B. fragilis is propagated in the rat tissue cage model of extraintestinal growth, and that this ability provides a competitive advantage in vivo over strains lacking the don locus.